- Home
- PTGX vs RLI Comparison
PTGX vs RLI Comparison
Compare PTGX & RLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PTGX | RLI |
|---|---|---|
| Founded | 2006 | 1965 |
| Country | United States | United States |
| Employees | N/A | 1193 |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 5.4B |
| IPO Year | 2016 | 1994 |
Fundamental Metrics
Financial Performance| Metric | PTGX | RLI |
|---|---|---|
| Price | $105.55 | $57.42 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 7 |
| Target Price | ★ $108.23 | $62.40 |
| AVG Volume (30 Days) | ★ 713.3K | 500.7K |
| Earning Date | 05-05-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 4.47% |
| EPS Growth | N/A | ★ 16.84 |
| EPS | N/A | ★ 4.37 |
| Revenue | N/A | ★ $1,882,448,000.00 |
| Revenue This Year | $873.97 | N/A |
| Revenue Next Year | N/A | $3.53 |
| P/E Ratio | ★ N/A | $13.50 |
| Revenue Growth | N/A | ★ 6.33 |
| 52 Week Low | $41.29 | $55.80 |
| 52 Week High | $107.84 | $79.55 |
Technical Indicators
Market Signals| Indicator | PTGX | RLI |
|---|---|---|
| Relative Strength Index (RSI) | 59.61 | 42.84 |
| Support Level | $76.63 | $55.86 |
| Resistance Level | $107.84 | $59.31 |
| Average True Range (ATR) | 4.03 | 1.22 |
| MACD | -0.12 | 0.16 |
| Stochastic Oscillator | 84.57 | 40.67 |
Price Performance
Historical ComparisonAbout PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About RLI RLI Corp. (DE)
RLI Corp underwrites property and casualty insurance through its subsidiaries. The company offers insurance coverage in the specialty admitted market, where the products are designed for special risks. It also offers products in the excess and surplus markets, which provides an alternative for customers with risks or loss exposures that generally cannot be written in the standard admitted market. RLI distributes property and casualty insurance through its wholly-owned branch offices that market to wholesale and retail producers. The company's insurance operation segments include Casualty, Property, and Surety, and it derives a majority of its revenue from the Casualty segment.